Clinical Studies Blog | Seattle Clinical Research Center

Seattle Clinical Research Center Recognizes FDA Approval of Elinzanetant (Lynkuet) for Moderate to Severe Hot Flashes Following Clinical Trial Participation

October 31, 2025

Seattle, WA – October 24, 2025 – Seattle Clinical Research Center (SCRC) is proud to recognize the recent FDA approval of elinzanetant (brand name Lynkuet), developed by Bayer, for the treatment of moderate to severe vasomotor symptoms (hot flashes) associated with menopause. SCRC participated in multiple clinical trials evaluating elinzanetant, contributing to the pivotal data that helped support its approval. As a

Seattle Clinical Research Center Contributes to FDA Approval of New Migraine Treatment

May 9, 2025

Seattle, WA – May 9, 2025 – Seattle Clinical Research Center (SCRC) is proud to share that a new treatment for migraine—Atzumi™ (dihydroergotamine) nasal powder—has been approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura in adults. SCRC was one of the clinical trial sites for the pivotal Phase

Seattle Clinical Research Center Recognizes FDA Approval of New Non-Hormonal Copper IUD Following Clinical Trial Participation

March 5, 2025

Seattle, WA – March 4, 2025 – Seattle Clinical Research Center is pleased to recognize the recent FDA approval of a new non-hormonal copper intrauterine device (IUD), now officially approved for up to three years of use. As one of the leading clinical trial sites involved in the pivotal Phase 3 study, Seattle Clinical Research Center contributed valuable research data

Seattle Clinical Research Center Relocating To New State-Of-The-Art Facility

March 13, 2024

Beginning April 1st, 2024, Seattle Clinical Research Center will be located at 633 Yesler Way, Seattle, WA 98104 SEATTLE, WA – Seattle Clinical Research Center (SCRC) is thrilled to announce our upcoming move to a new location, effective April 1st, 2024. The new facility is custom-built to accommodate our expanding operations and provide an enhanced

Two Prominent Clinical Research Sites Join Forces to Expand Reach, Expertise

October 12, 2021

SEATTLE – The clinical research site Seattle Women’s Health, Research and Gynecology has unveiled a new brand: Seattle Clinical Research Center (SCRC). SCRC has merged with its Renton-based sister site Rainier Clinical Research Center (RCRC), enabling both organizations to leverage infrastructure, best practices and 60 years of clinical trials and medical expertise. The merger expands

Gynecology Practice Closing August 2020

June 9, 2020

Dear Patients, Seattle Clinical Research Center will be closing our Gynecology practice on August 31, 2020. We will operate exclusively as a Clinical Research Center and none of our physicians will be providing medical care to patients outside of our research studies. I am honored to have served as your physician over the last 34

CORONAVIRUS / COVID-19 ANNOUNCEMENT

March 16, 2020

COVID-19 SAFE ENVIRONMENT UPDATE 5/18: It is our responsibility to prioritize the health of ourselves, our patients, and the rest of the community, especially those that are most vulnerable to the disease.We are now operating in a “COVID-19 safe environment”. This means that we are in full compliance with all Washington State, Washington Department of

Hot Flashes Affect 80% of Women: Research Trial Aims to Provide Potential New Options

February 13, 2020

Local physicians are seeking volunteers for hot flash clinical trials, aiming to find potential new treatment options. SEATTLE, WA – Hot flashes tend to be the most common complaint from women going through menopause. Women who are experiencing hot flashes may feel like they have limited treatment options, but local researchers are seeking alternative options.

In the News